Senator Charles Grassley (R) continues to push a bipartisan bill to lower prescription drug prices as Congress pares back the issue included in President Joe Biden’s Build Back Better social spending plan, which is still under negotiation.

Democrats announced an agreement Tuesday that would allow Medicare Parts B and D to negotiate prices directly with drug manufacturers on certain drugs and cap out-of-pocket spending for seniors at $2,000 per year. The proposal also includes a tax penalty for drug companies that increase their prices at a greater rate than the national inflation. The original, more expansive version of the bill titled the Lower Drug Costs Now Act passed twice in the House of Representatives but has been stalled in the Senate by some democratic senators.

Senator Grassley spoke on the chamber floor recently to support his plan titled the Prescription Drug Pricing Reduction Act which was first introduced in 2019, “And I figure the extreme way that the Democrats are approaching it, because some Democrats don’t want to do it the way Pelosi does it, that they’re eventually going to have to come to my bipartisan bill that I got out of committee 19-9 called the Grassley-Wyden bill, Wyden is a Democrat from Oregon.”

Grassley’s plan is said to include a cap for yearly out-of-pocket drug costs for seniors at $3,100, prevent drug costs from growing faster than the consumer price index, and end uncapped taxpayer-funded subsidies to “Big Pharma.” The $1.75 trillion Build Back Better Act would address climate change, bring aid to families, and expand access to health care.